← FDA Drug Approvals (Drugs@FDA)

FUROSEMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2024-12-13

Drug application

FDA Application #
ANDA217557
Application type
Abbreviated New Drug Application (Generic)
Brand name
FUROSEMIDE
Generic name
FUROSEMIDE
Active ingredients
FUROSEMIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
ASPIRO
Manufacturer
Camber Pharmaceuticals, Inc.
First approval
2024-12-13

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown